OmniAb Q4 rev $10.8M, net loss $13.1M; guides FY25 rev $20-25M, opex $90-95M

OmniAb, Inc.

Q4 revenue $10.8M (up from $4.8M YoY); net loss $13.1M ($0.12/shr) vs $14.1M loss prior year.
FY2024 revenue $26.4M (down from $34.2M); net loss $62.0M ($0.61/shr) vs $50.6M loss in 2023.
Cash and investments $59.4M at Dec 31, 2024; expects 2025 cash use below 2024's $38.9M.
2025 guidance: revenue $20-25M, operating expense $90-95M, effective tax rate ~0%.
91 active partners, 363 active programs; 10 new license agreements in 2024 (incl. Incyte, Photinia).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.